Literature DB >> 20068407

Non-human primate immune libraries combined with germline humanization: an (almost) new, and powerful approach for the isolation of therapeutic antibodies.

Thibaut Pelat1, Philippe Thullier.   

Abstract

Panning of libraries constructed from immunised non-human primates (NHP) has not been widely used, even though this has proven to be a successful approach for the isolation of human-like antibody fragments with affinities in the nanomolar to the picomolar range. As recently demonstrated, after initial isolation of antibodies with such high affinities, germline humanization may be applied to these Fabs or scFvs to increase the similarity of their framework regions with those encoded by human germline genes. 'Germlinized' antibody fragments may be converted to full size IgGs; indications are given that these IgGs could be better tolerated in clinical use than human antibodies. The use of the combination of NHP immune libraries and germline humanization thus may compete with use of libraries of human origin, whether naïve or immune, and with synthetic libraries. In this report, the various approaches will be compared, and advantages of the two-step NHP-based method, as well as corresponding intellectual property aspects, will be discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20068407      PMCID: PMC2726609          DOI: 10.4161/mabs.1.4.8635

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  28 in total

Review 1.  A model for neutralization of viruses based on antibody coating of the virion surface.

Authors:  D R Burton; E O Saphire; P W Parren
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

2.  Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries.

Authors:  Peter Amersdorfer; Cindy Wong; Theresa Smith; Steven Chen; Sharad Deshpande; Robert Sheridan; James D Marks
Journal:  Vaccine       Date:  2002-02-22       Impact factor: 3.641

Review 3.  IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains.

Authors:  Marie-Paule Lefranc; Christelle Pommié; Manuel Ruiz; Véronique Giudicelli; Elodie Foulquier; Lisa Truong; Valérie Thouvenin-Contet; Gérard Lefranc
Journal:  Dev Comp Immunol       Date:  2003-01       Impact factor: 3.636

4.  A high-affinity macaque antibody Fab with human-like framework regions obtained from a small phage display immune library.

Authors:  Stéphanie Chassagne; Emmanuelle Laffly; Emmanuel Drouet; Francis Hérodin; Marie-Paule Lefranc; Philippe Thullier
Journal:  Mol Immunol       Date:  2004-07       Impact factor: 4.407

Review 5.  Somatic generation of antibody diversity.

Authors:  S Tonegawa
Journal:  Nature       Date:  1983-04-14       Impact factor: 49.962

6.  Human antibodies from immunized donors are protective against anthrax toxin in vivo.

Authors:  Martha A Wild; Hong Xin; Toshiaki Maruyama; Mary Jean Nolan; Peter M Calveley; John D Malone; Mark R Wallace; Katherine S Bowdish
Journal:  Nat Biotechnol       Date:  2003-10-12       Impact factor: 54.908

7.  Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity.

Authors:  Thibaut Pelat; Michael Hust; Martha Hale; Marie-Paule Lefranc; Stefan Dübel; Philippe Thullier
Journal:  BMC Biotechnol       Date:  2009-06-30       Impact factor: 2.563

8.  Allergic asthma and an anti-CD23 mAb (IDEC-152): results of a phase I, single-dose, dose-escalating clinical trial.

Authors:  Lanny J Rosenwasser; William W Busse; Richard G Lizambri; Teresa A Olejnik; Mark C Totoritis
Journal:  J Allergy Clin Immunol       Date:  2003-09       Impact factor: 10.793

Review 9.  Immunogenicity of therapeutic proteins: clinical implications and future prospects.

Authors:  Huub Schellekens
Journal:  Clin Ther       Date:  2002-11       Impact factor: 3.393

10.  Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages.

Authors:  Nehal Mohamed; Juan Li; Claudia S Ferreira; Stephen F Little; Arthur M Friedlander; George L Spitalny; Leslie S Casey
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

View more
  17 in total

1.  A comparison of human and macaque (Macaca mulatta) immunoglobulin germline V regions and its implications for antibody engineering.

Authors:  Philippe Thullier; Siham Chahboun; Thibaut Pelat
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

2.  Comparing CDRH3 diversity captured from secondary lymphoid organs for the generation of recombinant human antibodies.

Authors:  Sophie Venet; Marie Kosco-Vilbois; Nicolas Fischer
Journal:  MAbs       Date:  2013-07-02       Impact factor: 5.857

3.  5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland.

Authors:  Alain Beck; Janice M Reichert; Thierry Wurch
Journal:  MAbs       Date:  2010 Mar-Apr       Impact factor: 5.857

4.  Generation and characterization of protective antibodies to Marburg virus.

Authors:  Jeffrey W Froude; Thibaut Pelat; Sebastian Miethe; Samantha E Zak; Anna Z Wec; Kartik Chandran; Jennifer Mary Brannan; Russell R Bakken; Michael Hust; Philippe Thullier; John M Dye
Journal:  MAbs       Date:  2017-03-13       Impact factor: 5.857

5.  Transferring the characteristics of naturally occurring and biased antibody repertoires to human antibody libraries by trapping CDRH3 sequences.

Authors:  Sophie Venet; Ulla Ravn; Vanessa Buatois; Franck Gueneau; Sébastien Calloud; Marie Kosco-Vilbois; Nicolas Fischer
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

6.  Mapping the epitopes of a neutralizing antibody fragment directed against the lethal factor of Bacillus anthracis and cross-reacting with the homologous edema factor.

Authors:  Philippe Thullier; Arnaud Avril; Jacques Mathieu; Christian K Behrens; Jean-Luc Pellequer; Thibaut Pelat
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

7.  Rapid Generation of Human-Like Neutralizing Monoclonal Antibodies in Urgent Preparedness for Influenza Pandemics and Virulent Infectious Diseases.

Authors:  Weixu Meng; Weiqi Pan; Anna J X Zhang; Zhengfeng Li; Guowei Wei; Liqiang Feng; Zhenyuan Dong; Chufang Li; Xiangjing Hu; Caijun Sun; Qinfang Luo; Kwok-Yung Yuen; Nanshan Zhong; Ling Chen
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

8.  Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin.

Authors:  Siham Chahboun; Michael Hust; Yvonne Liu; Thibaut Pelat; Sebastian Miethe; Saskia Helmsing; Russell Ga Jones; Dorothea Sesardic; Philippe Thullier
Journal:  BMC Biotechnol       Date:  2011-11-23       Impact factor: 2.563

9.  Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivo.

Authors:  Torsten Rülker; Luzie Voß; Philippe Thullier; Lyn M O' Brien; Thibaut Pelat; Stuart D Perkins; Claudia Langermann; Thomas Schirrmann; Stefan Dübel; Hans-Jürgen Marschall; Michael Hust; Birgit Hülseweh
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

10.  Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E.

Authors:  Sebastian Miethe; Christine Rasetti-Escargueil; Arnaud Avril; Yvonne Liu; Siham Chahboun; Hannu Korkeala; Christelle Mazuet; Michel-Robert Popoff; Thibaut Pelat; Philippe Thullier; Dorothea Sesardic; Michael Hust
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.